Micromet to Present at the 28th Annual J.P. Morgan Healthcare Conference

Friday, January 8, 2010 Press Release
Email Print This Page Comment
Font : A-A+

BETHESDA, Md., Jan. 7 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI) today announced that it will participate in

the 28th Annual J.P. Morgan Healthcare Conference, to be held January 11th – 14th in San Francisco.  Christian Itin, Ph.D., Micromet's President and CEO, will present a 30 minute corporate
overview on Thursday, January 14th at 12:30 PM PST.

The presentation will be webcast live and may be accessed by visiting the Micromet website at www.micromet-inc.com. A replay of the webcast will be available for 90 days.

About Micromet, Inc.

Micromet, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibody-based therapies for the treatment of cancer. Its product development pipeline includes novel antibodies generated with its proprietary BiTE® technology, as well as conventional monoclonal antibodies. Two of Micromet's BiTE antibodies and three of its conventional antibodies are currently in clinical trials. Micromet has collaborations with a number of leading pharmaceutical and biotechnology companies, including sanofi-aventis, Bayer Schering Pharma, Merck Serono, MedImmune and Nycomed. Additional information can be found at www.micromet-inc.com.

SOURCE Micromet, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook